TCI Wealth Advisors’s Lisata Therapeutics LSTA Stock Holding History

TCI Wealth Advisors’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20	Closed	-$1K	–	1601
2020 Q3	$1K	Buy	+20	New	+$632	﹤0.01%	1358

Other funds holding LSTA

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCI Wealth Advisors's LSTA Position: Q4 2020 in Review

TCI Wealth Advisors sold out of Lisata Therapeutics (LSTA) in Q4 2020, closing a stake of 20 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in LSTA in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 33 funds tracked by Wall St. Rank hold LSTA as of Q4 2020.

TCI Wealth Advisors reported no remaining Lisata Therapeutics position as of Q4 2020 after selling out during the quarter.
TCI Wealth Advisors sold 20 Lisata Therapeutics shares in Q4 2020, an estimated $1K.
TCI Wealth Advisors first reported a position in Lisata Therapeutics in Q3 2020 and held it in 1 quarter.
TCI Wealth Advisors's Lisata Therapeutics position peaked at $1K in Q3 2020.
33 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2020.

Based on TCI Wealth Advisors's 13F filing for Q4 2020, filed 21 Jan 2021.